Cipla Close To Commit $1 Billion To Moderna For Booster Vaccine In India: Report
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
United Kingdom Us Countermeasures Injury Compensation Program Cipla Close To Commit Over For Moderna Booster Vaccine In India Liberalised Pricing Accelerated National
Source: ndtv.com